v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash Flows From Operating Activities:    
Net income (loss) $ (18,799) $ 96,888
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 12,991 14,942
Amortization of debt discount 594 631
Non-cash operating lease expense 2,438 4,037
Unrealized (gain) loss on investments in equity securities 469 (613)
Realized loss on available-for-sale investments 1,426 1,888
Gain on divested business   (120,351)
Stock-based compensation expense 4,797 6,075
Loss on disposal of property and equipment 64 105
Change in credit losses (40) 48
Excess and obsolete inventory 36 (36)
Change in contingent consideration 48 (5,206)
Changes in operating assets and liabilities:    
Accounts receivable (3,143) (5,945)
Inventories 1,671 (1,667)
Prepaid expenses and other current assets 2,812 3,188
Deposits 16 (170)
Operating lease liabilities (2,284) (2,935)
Accounts payable and other accrued expenses 1,234 (2,594)
Accrued compensation and related expenses (754) (1,568)
Deferred revenue 787 519
Net deferred tax liability 503 1,077
Net cash provided by (used in) operating activities 4,866 (11,687)
Cash Flows From Investing Activities:    
Purchases of property and equipment (19,084) (7,519)
Software development costs (381) (2,062)
Proceeds from divested business   210,239
Sales/maturities of short-term investments 33,000 36,001
Patent and trademark costs (630) (698)
Net cash provided by investing activities 12,905 235,961
Cash Flows From Financing Activities:    
Proceeds from exercise of stock options 1,030 2,950
Repurchase of common stock   (4,259)
Repayment of notes payable (70) (80)
Repayment of 2025 Convertible Senior Notes   (14,344)
Repayment of finance lease liabilities (222) (320)
Net cash provided by (used in) financing activities 738 (16,053)
Effect of exchange rates on cash and cash equivalents 264 (10,094)
Net change in cash and cash equivalents 18,773 198,127
Cash and cash equivalents - beginning of period 250,494 45,289
Cash and cash equivalents - end of period 269,267 243,416
Reconciliation of cash and cash equivalents to the condensed consolidated balance sheets:    
Cash and cash equivalents from continuing operations - beginning of period 250,494 34,137
Cash and cash equivalents from discontinued operations (included in current assets held for sale) - beginning of period   11,152
Total cash and cash equivalents - beginning of period 250,494 45,289
Cash and cash equivalents from continuing operations - end of period 269,267 243,416
Total cash and cash equivalents - end of period 269,267 243,416
Supplemental Disclosure of Cash Flow Information:    
Cash paid for interest 754 921
Cash paid for income taxes 752 626
Supplemental Disclosure of Non-Cash Financing Activities:    
Operating lease right-of-use assets and operating lease liabilities 3,198 2,491
Net unrealized gain on available-for-sale debt securities 123 1,173
Reclassification of realized gain on available-for-sale debt securities to earnings 1,484 2,203
Paid-in-kind preferred stock dividend 4,000 4,000
Intangible assets included in property and equipment 3,633  
Fixed asset purchases included in accounts payable and accrued liabilities 207 269
Contingent consideration reclassed to accounts payable and accrued liabilities   869
Purchase of equipment through finance lease obligation $ 247 $ 377

Source

10-Q PDF XBRL Zip